Leonard Powell Mertz bought $250K of Alpha Cognition (ACOG)
Executed Aug 18 2025, disclosed Aug 20 2025, 2 days later.
Over the 21 trading sessions from the disclosed entry session (Aug 20 2025), the stock returned +8.6% (delay-adjusted); from the execution session (Aug 18 2025), +8.9%. Derived: entry at the session's open, exit at the close 20 sessions later.
Leonard Powell Mertz (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Alpha Cognition Inc. Common Stock (ACOG). Across 1 priced purchase filing, the average 21-session return was +8.9% from execution and +8.6% from disclosure (delay-adjusted; derived). The largest single filing was $250K of ACOG (27,778 sh × $9.00, as filed), executed Aug 18 2025.
Healthcare · Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative d…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→